
Vildagliptin (50mg)
Active composition
Vildagliptin inhibits DPP-4, leading to increased levels of incretin hormones, which stimulate insulin secretion and decrease glucagon levels.
Medical applications
Nexglipt 50 Tablet contains Vildagliptin (50mg), an oral diabetes medication used in combination with diet and exercise to manage type 2 diabetes. It works by increasing the levels of insulin in the body and reducing the amount of sugar produced by the liver. This tablet is prescribed when oral antidiabetic agents are insufficient for adequate glycemic control, or when these agents are contraindicated or not tolerated. It should be used under the supervision of a healthcare professional. Common side effects include headache, nasopharyngitis, and upper respiratory tract infection. It is essential to follow the prescribed dosage and regular monitoring of blood glucose levels is necessary. Consult a healthcare provider before making any changes to the dose or discontinuing the medication.
Pyrrolidine-carbonitrile derivative
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Nexglipt 50 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Nexglipt 50 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Nexglipt 50 Tablet is safe to use in patients with kidney disease. No dose adjustment of Nexglipt 50 Tablet is recommended. However, in patients with moderate to severe kidney disease, dose adjustment may be required. Consult with your doctor.
Exercise Caution
Nexglipt 50 Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Nexglipt 50 Tablet is probably unsafe to use in patients with liver disease and should be avoided. Please consult your doctor.
Regular Checkup
0 reviews for Nexglipt 50 Tablet

Vildagliptin (50mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
Vildagliptin inhibits DPP-4, leading to increased levels of incretin hormones, which stimulate insulin secretion and decrease glucagon levels.
Medical applications
Nexglipt 50 Tablet contains Vildagliptin (50mg), an oral diabetes medication used in combination with diet and exercise to manage type 2 diabetes. It works by increasing the levels of insulin in the body and reducing the amount of sugar produced by the liver. This tablet is prescribed when oral antidiabetic agents are insufficient for adequate glycemic control, or when these agents are contraindicated or not tolerated. It should be used under the supervision of a healthcare professional. Common side effects include headache, nasopharyngitis, and upper respiratory tract infection. It is essential to follow the prescribed dosage and regular monitoring of blood glucose levels is necessary. Consult a healthcare provider before making any changes to the dose or discontinuing the medication.
Pyrrolidine-carbonitrile derivative
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Nexglipt 50 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Nexglipt 50 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Nexglipt 50 Tablet is safe to use in patients with kidney disease. No dose adjustment of Nexglipt 50 Tablet is recommended. However, in patients with moderate to severe kidney disease, dose adjustment may be required. Consult with your doctor.
Exercise Caution
Nexglipt 50 Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Nexglipt 50 Tablet is probably unsafe to use in patients with liver disease and should be avoided. Please consult your doctor.
Regular Checkup
0 reviews for Nexglipt 50 Tablet













